Your cart is currently empty!
Our High Sensitivity Biomarker Assay combines the power of the ARGO™ HT system with NULISA™—a next-gen immunoassay platform that achieves attomolar-level detection. Built on Alamar Biosciences’ dual-capture-and-release innovation, this assay delivers ultra-low detection limits and broad multiplexing for critical biomarkers in plasma, CSF and other biofluids, as well as some critical tissues such as brain homogenates.

At Allumiqs, data is not just a byproduct – it’s the engine of insight. Our enriched data analysis transforms raw datasets into actionable intelligence, empowering you to make confident, informed decisions faster.


Working with Allumiqs means stepping into a powerful ecosystem designed to put customer success at the forefront. With a passionate team of scientists and a growing network of world-class channel partners, Allumiqs delivers more than just expertise—it fosters collaboration, transparency, and tailored solutions, making complex challenges feel simple.


Unlock the future of biomarker analysis with our High Sensitivity Biomarker Assay powered by ARGO™ HT + NULISA™. Whether you’re validating candidate proteins or profiling complex immune signatures, achieve unprecedented sensitivity and multiplexing in one platform.
Contact us to discuss sample types, panel customization, pricing, and timelines.
In-depth profiling of many classes of biologically relevant lipids using our high resolution instruments.
Sample profiling using either untargeted metabolomics or selected panels of targeted metabolites is the best technique.
We help customers unlock the value and potential of their data with clearer, deeper insights.
